-
Big Response to Government’s Low-Cost Insurance Schemes in India
The low-premium life and accident insurance schemes introduced by the government recently have elicited huge response, attracting 11 crore subscribers in just three months.
- Categories
- Health Care
- Region
- South Asia
-
Viewpoint: The Ebola Vaccine We Needed
About 27,000 people in West Africa have been infected with the Ebola virus and more than 11,000 of them have died since the outbreak began last year. Many could have been saved if an effective vaccine had been available. But the world relies on drug companies to create new vaccines and medications, and they have no financial incentive to do so for diseases that mostly affect poor countries. Clearly, the world needs a better mechanism for vaccine development.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Can Microfinance Help Boost Sanitation Coverage?
The time when microfinance was seen as the miracle cure to lift people out of poverty is long gone. The funding crisis in India in 2010 and evidence of mixed impacts from microfinance have contributed to a greater understanding of both its strengths and weaknesses. While microfinance is usually associated with income generation, rather than taps and toilets, growing evidence shows that it could be a solution for funding sanitation facilities in developing countries.
- Categories
- Health Care
- Region
- South Asia
-
Viewpoint: TPP’s Outcome Pivotal for Future of Global Biomedical Innovation
After seven years of wrangling toward the final terms of an ambitious free trade agreement that will join 12 Asia-Pacific nations, only the thorniest of market access and intellectual property issues remain unresolved in the Trans-Pacific Partnership (TPP). Of these, perhaps the most contentious concerns how long pharmaceutical companies should have exclusive intellectual property rights covering the clinical trial data they compile as they develop novel biologic medicines. U.S. negotiators have stood fast in advocating for 12 years of data protection — the standard that Congress enshrined into U.S. law following extensive deliberation — while other TPP parties have sought to limit the regulatory data protection period to as little as five to seven years.
- Categories
- Health Care
- Tags
- public policy
-
Health Solutions for Rural India
How do you design a developmental solution or provide a digital tool for a poor and inaccessible area where visitors are tracked by Maoists? An area so remote that barely any telecom network works, where more than 90% of the population lives in villages.
- Categories
- Health Care
-
Weekly Roundup – 8/15/15: Coke goes fact-free in a week of missteps by multinational organizations
It's not easy being big. Especially when NextBillion's editors are on the lookout for Roundup fodder. This week we sharpened our elbows to take on Coke, the United Nations, Google ... and even the Catholic church. Let us know if you agree with our opinions; we'd love to run some counterpoints in an upcoming Roundup.
- Categories
- Health Care, Technology
- Tags
- public health
-
Why drug companies are betting big on ‘pharmerging’ countries
Developing countries like China, Brazil and India will drive nearly half of the growth in drug spending in the near future. Here’s how Big Pharma could play the trend.
- Categories
- Health Care
-
Can randomized trials eliminate global poverty?
A new generation of economists is trying to transform global development policy through the power of randomized controlled trials.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.